Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

386890

	registered interest
	date	01/07/2015
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Defence
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government over what periods in the last 30 years there has been a threat to the existence of the United Kingdom; and what was the average percentage of gross domestic product spent on defence in each of those years.
	tabling member printed	Lord West of Spithead
	uin	HL999
	answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>The UK has, and continues to face, a broad range of complex threats both at home and abroad.</p><p>The table below shows the proportion of gross domestic product that the UK has spent on defence each year since 1985. This data is published annually by NATO as part of its Defence Expenditure publications.</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Percentage of GDP spent on Defence</strong></p></td></tr><tr><td><p>1985</p></td><td><p>5.2</p></td></tr><tr><td><p>1986</p></td><td><p>4.9</p></td></tr><tr><td><p>1987</p></td><td><p>4.6</p></td></tr><tr><td><p>1988</p></td><td><p>3.2</p></td></tr><tr><td><p>1989</p></td><td><p>4.1</p></td></tr><tr><td><p>1990</p></td><td><p>4.1</p></td></tr><tr><td><p>1991</p></td><td><p>4.3</p></td></tr><tr><td><p>1992</p></td><td><p>3.8</p></td></tr></tbody></table><p> </p><p> </p><table><tbody><tr><td><p>1993</p></td><td><p>3.6</p></td></tr><tr><td><p>1994</p></td><td><p>3.4</p></td></tr><tr><td><p>1995</p></td><td><p>3.1</p></td></tr><tr><td><p>1996</p></td><td><p>3</p></td></tr><tr><td><p>1997</p></td><td><p>2.7</p></td></tr><tr><td><p>1998</p></td><td><p>2.6</p></td></tr><tr><td><p>1999</p></td><td><p>2.5</p></td></tr><tr><td><p>2000</p></td><td><p>2.5</p></td></tr><tr><td><p>2001</p></td><td><p>2.5</p></td></tr><tr><td><p>2002</p></td><td><p>2.4</p></td></tr><tr><td><p>2003</p></td><td><p>2.4</p></td></tr><tr><td><p>2004</p></td><td><p>2.2</p></td></tr><tr><td><p>2005</p></td><td><p>2.5</p></td></tr><tr><td><p>2006</p></td><td><p>2.4</p></td></tr><tr><td><p>2007</p></td><td><p>2.5</p></td></tr><tr><td><p>2008</p></td><td><p>2.6</p></td></tr><tr><td><p>2009</p></td><td><p>2.6</p></td></tr><tr><td><p>2010</p></td><td><p>2.6</p></td></tr><tr><td><p>2011</p></td><td><p>2.6</p></td></tr><tr><td><p>2012</p></td><td><p>2.2</p></td></tr><tr><td><p>2013</p></td><td><p>2.3</p></td></tr><tr><td><p>2014</p></td><td><p>2.2</p></td></tr><tr><td><p>2015</p></td><td><p>2.1</p></td></tr></tbody></table><p> </p> answering member printed Earl Howe question first answered 08/07/2015 15:34:22 answering member 2000 label Biography information for Earl Howe
	tabling member	3834 label Biography information for Lord West of Spithead

386889

	registered interest
	date	01/07/2015
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Iraq: Armed Conflict
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of whether driving Daesh out of Iraq would be a final military victory.
	tabling member printed	Lord West of Spithead
	uin	HL998
	answer	answer is ministerial correction date of answer 07/07/2015 answer text <p>ISIL must be defeated both in Iraq and Syria. This will take time and patience but it is a fight we must win. We are also clear that it cannot be achieved by military action alone which is why the UK supports inclusive governance in Iraq and political transition in Syria.</p> answering member printed Earl Howe question first answered 07/07/2015 16:05:34 answering member 2000 label Biography information for Earl Howe
	tabling member	3834 label Biography information for Lord West of Spithead

386888

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL997
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL995 HL996 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386887

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL996
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL995 HL997 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386886

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis and Multiple Myeloma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL995
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL996 HL997 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386885

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Multiple Myeloma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when they expect the National Institute of Health Research Technology Assessment programme to publish initial findings from its assessment of the benefits of antibiotic prophylaxis and its effect on healthcare associated infections in myeloma patients.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL994
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>This trial is led by the University of Birmingham. The project is recruiting ahead of schedule and expects to reach its target of 800 in the near future. The target was to do so by the end of November 2015. Publication of initial findings is expected in 2017.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 13:00:57 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386884

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what progress has been made on setting up a study to image amyloid deposition in systemic amyloidosis using hybrid positron emission tomography-magnetic resonance imaging; where the study is located; how many patients have been recruited; when the study is expected to complete its initial work; and where the results will be published.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL993
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>This is a single centre study at University College London Hospital. It has now been set up and one patient has been recruited and scanned. The current planned date for end of recruitment is 1 October 2016. It is anticipated that the data will be analysed and submitted for publication in a peer reviewed journal within a year of the end of recruitment.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 14/07/2015 15:36:20 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386883

	registered interest
	date	01/07/2015
	answering body	Department for Energy and Climate Change
	answering dept id	63
	answering dept short name	Energy and Climate Change
	answering dept sort name	Energy and Climate Change
	hansard heading	Carbon Emissions
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what proportion of their 2020 carbon emissions reduction target they intend to achieve through the development of thermal heating capacity in the United Kingdom.
	tabling member printed	Lord Judd
	uin	HL992
	answer	answer is ministerial correction date of answer 07/07/2015 answer text <p>The Climate Change Act (2008) requires the Government to set legally binding ‘carbon budgets’ to meet the objective of reducing emissions by at least 80% in 2050 from 1990 levels. The Act requires that the UK’s emissions in the third carbon budget period, which covers 2020, are at least 34% below the 1990 baseline for emissions.</p><p>The Government has not set specific targets for how much of the emissions reductions required for each carbon budget should come from different emissions sources, for example heat, electricity or transport. This is to provide sufficient flexibility to ensure carbon savings are delivered across the economy in the most cost effective way.</p><p>However, DECC does produce projections of UK emissions that account for the impact of Government policies. The last projections published in September 2014 [1] showed that the UK was on track to meet the second (2013-17) and third (2018-22) budgets having already met the first carbon budget (2008-12).</p><p>In 2020, policies [2] which drive improvements in energy efficiency (across all sectors) are projected to contribute 61% of the total reduction in emissions and policies influencing the uptake of low-carbon heat technologies are projected to contribute 5%. Other policies such as Building Regulations also support the reduction of heat emissions from buildings for example through the requirement to install a condensing boiler in most cases when a boiler needs to be replaced.</p><p><em><strong>[1]</strong></em><em> Updated Energy and Emissions Projections: 2014 (DECC)</em></p><p><strong><em> [</em></strong><strong><em>2]</em></strong><em> Source: Annex D of the Updated Energy and Emissions Projections (EEP): 2014 (DECC). Based on all policies listed in EEP, including those introduced before as well as after the publication of the Low Carbon Transition Plan (LCTP) 2009</em></p><p> </p><p> </p><p> </p> answering member printed Lord Bourne of Aberystwyth grouped question UIN HL991 question first answered 07/07/2015 16:31:57 answering member 4282 label Biography information for Lord Bourne of Aberystwyth
	tabling member	1660 label Biography information for Lord Judd

386882

	registered interest
	date	01/07/2015
	answering body	Department for Energy and Climate Change
	answering dept id	63
	answering dept short name	Energy and Climate Change
	answering dept sort name	Energy and Climate Change
	hansard heading	Carbon Emissions
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what proportion of their 2020 carbon emissions reduction target they intend to achieve through energy efficiency measures.
	tabling member printed	Lord Judd
	uin	HL991
	answer	answer is ministerial correction date of answer 07/07/2015 answer text <p>The Climate Change Act (2008) requires the Government to set legally binding ‘carbon budgets’ to meet the objective of reducing emissions by at least 80% in 2050 from 1990 levels. The Act requires that the UK’s emissions in the third carbon budget period, which covers 2020, are at least 34% below the 1990 baseline for emissions.</p><p>The Government has not set specific targets for how much of the emissions reductions required for each carbon budget should come from different emissions sources, for example heat, electricity or transport. This is to provide sufficient flexibility to ensure carbon savings are delivered across the economy in the most cost effective way.</p><p>However, DECC does produce projections of UK emissions that account for the impact of Government policies. The last projections published in September 2014 [1] showed that the UK was on track to meet the second (2013-17) and third (2018-22) budgets having already met the first carbon budget (2008-12).</p><p>In 2020, policies [2] which drive improvements in energy efficiency (across all sectors) are projected to contribute 61% of the total reduction in emissions and policies influencing the uptake of low-carbon heat technologies are projected to contribute 5%. Other policies such as Building Regulations also support the reduction of heat emissions from buildings for example through the requirement to install a condensing boiler in most cases when a boiler needs to be replaced.</p><p><em><strong>[1]</strong></em><em> Updated Energy and Emissions Projections: 2014 (DECC)</em></p><p><strong><em> [</em></strong><strong><em>2]</em></strong><em> Source: Annex D of the Updated Energy and Emissions Projections (EEP): 2014 (DECC). Based on all policies listed in EEP, including those introduced before as well as after the publication of the Low Carbon Transition Plan (LCTP) 2009</em></p><p> </p><p> </p><p> </p> answering member printed Lord Bourne of Aberystwyth grouped question UIN HL992 question first answered 07/07/2015 16:31:57 answering member 4282 label Biography information for Lord Bourne of Aberystwyth
	tabling member	1660 label Biography information for Lord Judd

386881

	registered interest
	date	01/07/2015
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Crimes against Humanity
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they have taken to review the readiness of the United Kingdom to respond to crimes of atrocity and developing threats of genocide and other crimes against humanity anywhere in the world.
	tabling member printed	Lord Judd
	uin	HL990
	answer	answer is ministerial correction date of answer 13/07/2015 answer text <p>The British Government’s global network of embassies, strong international partnerships, and early warning mechanisms give the UK significant insight into emerging threats. The UK remains committed to the Responsibility to Protect and seeks to respond to developing threats of atrocity crimes or genocide including through prevention projects, sanctions regimes or support for justice systems. Our seat on the UN Security Council also means we swiftly engage where a threat of such crimes emerges. Where prevention has failed, it is the international community's responsibility to take collective action, through diplomatic, humanitarian and other means. Where necessary, the UN Security Council should be ready to authorise coercive measures under Chapter VII of the UN Charter.</p> answering member printed Baroness Anelay of St Johns question first answered 13/07/2015 13:24:48 answering member 3474 label Biography information for Baroness Anelay of St Johns
	tabling member	1660 label Biography information for Lord Judd